ST. DOMINIC-JACKSON MEMORIAL HOSPITAL JACKSON, MISSISSIPPI. CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) HEPARIN ANTICOAGULATION Page 1 of 5

Similar documents
Active UMMC Protocols

CRRT Interactive Hyperkalemia Cases AKI & CRRT conference 2018

CRRT Interactive Hyperkalemia Cases AKI & CRRT conference 2018

CRRT Procedures. and Guidelines. CRRT: Guidelines

CRRT Fundamentals Pre- and Post- Test. AKI & CRRT Conference 2018

Wales Critical Care & Trauma Network (North) CITRATE GUIDELINES (Approved May 2015)

Operation-Fluids-Electrolytes-Acid Base COMPLICATIONS OF DIALYSIS 2

CRRT Fundamentals Pre-Test. AKI & CRRT 2017 Practice Based Learning in CRRT

Admission Day 2 Na Potassium Cl Bicarb BUN Cr Hb Hct platelets

UAB CRRT Primer Ashita Tolwani, MD, MSc University of Alabama at Birmingham

CRRT Fundamentals Pre- and Post- Test Answers. AKI & CRRT 2017 Practice Based Learning in CRRT

MODALITIES of Renal Replacement Therapy in AKI

UNDERSTANDING THE CRRT MACHINE

Implementing therapy-delivery, dose adjustments and fluid balance. Eileen Lischer MA, BSN, RN, CNN University of California San Diego March 6, 2018

PICANet Custom Audit Definitions Renal Dataset

Diagnosis: Allergies with reaction type:

404FM.2 CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) USING CITRATE Target Audience: Hospital only ICU. (Based on Gambro and Kalmar Hospital protocols)

PICANet Custom Audit Definitions Renal Dataset

higher dose with progress in technical equipment. Continuous Dialysis: Dose and Antikoagulation. prescribed and delivered

Technical Considerations for Renal Replacement Therapy in Children

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

Managing Acid Base and Electrolyte Disturbances with RRT

Session 1: Circuit, Anticoagulation and Monitoring. Ashita Tolwani, MD, MSc Noel Oabel, BSN, RN, CNN 2019

CRRT in Pediatrics: Indications, Techniques & Outcome. Overview

*Sections or subsections omitted from the full prescribing information are not 6 ADVERSE REACTIONS

HNE Area Intensive Care. Continuous Renal Replacement Therapy in Intensive Care(CRRT)

DRUG ALLERGIES WT: KG

ALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked

CRRT: The Technical Questions Modality & Dose. Ashita J. Tolwani, MD, MSc University of Alabama at Birmingham 2018

Can We Achieve Precision Solute Control with CRRT?

Reference ID:

DONATION AFTER CARDIAC DEATH PLAN

BPG 03: Continuous Renal Replacement Therapy (CRRT)

Nurse-Pharmacist Collaboration in the Delivery of Continuous Renal Replacement Therapy

Less than 50kgs protocol

ADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center

CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT)

Essential in Renal Replacement Therapy Pediatrics CRRT

Section 3: Prevention and Treatment of AKI

Renal Replacement Therapy in ICU. Dr. Sunil Sharma Senior Resident Dept of Pulmonary Medicine

Recent advances in CRRT

ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES

Regional citrate anticoagulation for continuous renal replacement therapy without post-filter monitoring of ionized calcium

PICU CARD SURG Post Operative Cardiac Transplant Age LESS than 6 months (Page 1 of 5)

Can We Achieve Precision Solute Control with CRRT?

Module 8: Practice Problems

CRRT for the Experience User 1. Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference March, 2018

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS EPTIFIBATIDE (INTEGRILIN) PROTOCOL

Continuous Renal Replacement Therapy (CRRT)

Technical aspects of RRT in AKI: access, anticoagulation, drug dosage and nutrition. Marlies Ostermann

Regional Citrate Anticoagulation for RRTs in Critically Ill Patients with AKI

A quick reference guide to haemofiltration and renal failure

Diabetic Ketoacidosis

Dialysis in the Acute Setting

Organ Donor Management Recommended Guidelines ADULT CARDIAC DEATH (DCD)

Hypothermia Short Set-Critical Care HYPOTHERMIA SS- CRITICAL CARE

Kit Assembly. Enhanced Simplicity OPERATIONAL BENEFITS. Automatic venous chamber adjustment. User friendly interface

2019 Home Hemodialysis Standing Orders

ECMO & Renal Failure Epidemeology Renal failure & effect on out come

PICANet Renal Dataset supplement Renal Daily Interventions

COMPLIANCE WITH THIS DOCUMENT IS MANDATORY

Citrate Anticoagulation

Arterial blood gas Capillary blood glucose every hour. Continue to monitor hourly capillary blood glucose as per protocol (See Appendix A and B)

03/19/2019. Michael Zappitelli, MD, MSc Hospital for Sick Children, Toronto. Symposium on Pediatric Dialysis, ADC, Dallas, 2019

Arterial blood gas Capillary blood glucose every hour. Continue to monitor hourly capillary blood glucose as per protocol (See Appendix A and B)

Self-Learning Packet 2008

Pediatric Intensive Care Unit (PICU) Pediatric Diabetic Ketoacidosis (DKA) Admission Order Set

Pediatric Continuous Renal Replacement Therapy

Clinical Application of CRRT for Infants and Children

Organ Donor Management Recommended Guidelines ADULT Brain Death (NDD)

Prolonged Dialysis: 24-hr SLED Is It CRRT? Balazs Szamosfalvi, MD

Heparin Drip. Ordering

Nutrition Care Process: Case Study B Examples of Charting in Various Formats

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

DKA Adult ICU Powerplan

WEIGHT: KG HEIGHT: CM ALLERGY CAUTION sheet reviewed Code Status Full code

Neurosurgery Pre-Op [1710] Patient Name MRN. General. Nursing. Case Request [ ] Case request operating room Scheduling/ADT, Scheduling/ADT [ ] Other

Continuous Renal Replacement Therapy in PICU: explanation/definitions/rationale/background

Accelerated Venovenous Hemofiltration: Early Technical and Clinical Experience

1. Diagnosis: 2. Co-Morbidities: Allergies: NKDA Allergic to:

A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid base status*

IV Fluids Nursing B23 Objectives Serum Osmolality 275 to 295 Isotonic

Education Pack and Workbook for Citrate Anticoagulation via Prismaflex

Metabolismo del citrato nei pazienti critici. Filippo MARIANO Dipartimento di Area Medica, SCDO di Nefrologia e Dialisi Ospedale CTO, Torino

FLUIDS AND ELECTROLYTES

Module 10 Troubleshooting Guide

Package leaflet: information for the user. Prismasol 2 mmol/l Potassium Solution for haemodialysis/haemofiltration

Physician Orders LEB PICU Status Epilepticus Plan. [ ] No known allergies

POST-OP CARDIAC SURGERY PHYSICIAN S ORDER SHEET USE BALLPOINT PEN ONLY. CARDIAC INTENSIVE CARE UNIT

Renal replacement therapy in Pediatric Acute Kidney Injury

Chronic Maintenance In-Center Hemodialysis Standing Orders

ASN Board Review: Acute Renal Replacement Therapies

Management of the patient with established AKI. Kelly Wright Lead Nurse for AKI King s College Hospital

Acute Therapy Systems. Product Range

THERAPEUTIC PLASMA EXCHANGE

DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014

Jo Kuehn, RN, MSN, CPHQ Jenell Westhoven, RN, BSN

Electrolytes Solution

IV Fluids. Nursing B23. Objectives. Serum Osmolality

Matthew J Brain, Owen S Roodenburg, Natalie Adams, Phoebe McCracken, Lisen Hockings, Steve Musgrave, Warwick Butt and Carlos Scheinkestel.

Transcription:

HEPARIN ANTICOAGULATION Page 1 of 5 Pharmacy Mnemonic: CRRTHEP1 PATIENT DATA: DIAGNOSIS: AKI ESRD Other: WEIGHT: Today: kg Admission Weight:: kg Dry Weight: kg Access TYPE: Temporary Dialysis Catheter Tunneled Dialysis Catheter LOCATION: Internal Jugular Right Left Femoral Right Left Other: Catheter Lock Solution: 4% Trisodium Citrate Heparin (1000 IU/mL) Other: MODE OF THERAPY: CVVHDF CVVHD CVVH SCUF RECORD ON SIDE OF FILTER THE DATE AND TIME THE TREATMENT BEGAN Filter Set: HF 1400 Prime options: Heparin Flush followed by Normal Saline Rinse(add 10cc Heparin 1000 units/ml to 1 liter of 0.9% normal saline flushed through circuit followed by another 1 Liter of 0.9% normal saline flushed through circuit) LABS: Normal Saline (2 liters) (NO HEPARIN) Potassium, Sodium, Chloride, Bicarbonate, Creatinine, BUN, Magnesium, Ionized Calcium, Phosphorus PT/PTT CBC Lactic Acid Total Calcium ABG Other: At initiation, then at 3 AM, 11 AM, and 7 PM At 3 AM and then 3 PM Other: HEPARIN ANTICOAGULATION LOW DOSE HEPARIN ANTICOAGULATION (USE SYRINGE PUMP FOR HEPARIN INFUSION) HEPARIN (concentration 1,000 units/ml) ( i.e. 500 units/hour = 0.5 ml/hr, 1,000 units/hour = 1 ml/hr ) BOLUS LOADING DOSE: UNITS IV RATE: UNITS/HOUR. HIGH DOSE HEPARIN ANTICOAGULATION (MEDICATION INFUSION PUMP) HEPARIN LOAD DOSE: UNITS IV, then HEPARIN 25,000 UNITS IN 250 ml 0.45% SODIUM CHLORIDE at ml/hour FOR HEPARIN ANTICOAGULATION ONLY PTT EVERY 6 HOURS If PTT is less than 35, repeat loading dose and increase hourly by 3 ml/hour. If PTT is 35 to 50, repeat 50% of loading dose, and increase hourly by 2 ml/hour. If PTT is 51 70, no change in rate, at goal. If PTT is 71 90, decrease hourly by 2 ml/hour. If PTT is greater than 90, stop infusion x 1 hour, then resume with decrease of 2 ml/hour. *NOTIFY MD IF RATE IS GREATER THAN 2,000 UNITS/HR *MAX RATE IS 5,000 UNITS/HR.

HEPARIN ANTICOAGULATION Page 2 of 5 Pharmacy Mnemonic: CRRTHEP2 Blood Flow Rate: ml/minute Recommended minimum flow rate of 200 ml/minute Replacement Solution and Flow Rate: Total Replacement Rate: ml per hour: Standard Rate 25 ml/kg/hr Predilution Replacement Fluid at % Postdilution Replacement Fluid at % MAY USE PRISMASATE OR PRIMASOL AS REPLACEMENT FLUID BUT MAY NEED ADDITIVES!! MAY PLACE ANY PERCENTAGE OF REPLACEMENT FLUID PRE OR POST FILTER!! PRISMASOL PRISMASATE Normal Bicarbonate KCl: 4 meq/l B 22 GK 4/0 Normal Bicarbonate KCl: 4 meq/l B 22 GK 4/0 High Bicarbonate KCl: 4 meq/l BGK 4/0/1.2 High Bicarbonate KCl: 0 meq/l BK 0/3.5 High Bicarbonate KCl: 2 meq/l BGK 2/0 High Bicarbonate KCl: 2 meq/l BK 2/0 ADD TO ABOVE INDICATED FLUIDS: Dialysate Fluid: RATE: ml/hour ( CVVHDF or CVVHD) (USE GREEN CALES) Standard = No Dialysate Normal Bicarbonate with 4 meq/l KCL ( B 22 GK 4/0 Prismasate ) High Bicarbonate with 2 meq/l KCL ( BK 2/0 Prismasate ) High Bicarbonate with 0 meq/l KCL and 3.5 meq/l Ca++ ( BK 0/3.5 Prismasate ) ADD TO ABOVE INDICATED Prismasate : NET VOLUME BALANCE: Match input with output Net Volume Negative - ml/hour up to L per 24 hours No Fluid Pull Other: Consult Pharmacy for drug dosing while on CRRT. Consult Pharmacy to concentrate all fluids. **ALWAYS Notify pharmacy when CRRT is initiated, discontinued. or placed on hold for any reason.**

HEPARIN ANTICOAGULATION Page 3 of 5 Pharmacy Mnemonic: CRRTHEP3 Notify Nephrologist if and when FILTER clots. Notify Nephrologist if ACCESS PRESSURES continue to trend toward out of range. (See Table Below) Notify Nephrologist if bicarbonate is < 15 mmol/l or > 30 mmol/l after 12 hours of therapy. OPTIONAL: Electrolyte Replacement Infuse Electrolyte Replacements ONLY while CRRT is running. Discontinue all electrolyte replacement infusions when CRRT is disconnected for ANY reason. Calcium Gluconate: 25 grams in 250 ml Normal Saline (total volume 500 ml) Infusion rate: grams/24 hours **Always Infuse Calcium Gluconate post filter via y-connector between circuit and catheter return lumen Sodium Phosphate: 30 mmol in 250 ml Normal Saline (total volume = 260 ml) Infusion rate: mmol/24 hours Potassium Phosphate: 30 mmol in 250 ml Normal Saline (total volume = 260 ml) Infusion rate: mmol/24 hours Magnesium Sulfate: 4 grams in 100 ml Water for Injection (total volume = 100 ml ) Infusion rate: grams/24 hours **** Hold for Mg++ levels > 2 Daily Weights

HEPARIN ANTICOAGULATION Page 4 of 5 STANDARD SOLUTIONS USED DURING CRRT: ******************************************************************************************************************************* NORMAL BICARBONATE SOLUTIONS: HIGH BICARBONATE 0 K+ SOLUTIONS: HIGH BICARBONATE 2 K+ SOLUTIONS Prismasate B22GK 4/0 5000 ml Prismasate BK 0/3.5 5000 ml Prismasate BK 2/0 5000 ml Potassium 4 meq/l 0.0 2 meq/l Calcium 0.0 3.5 meq/l 0.0 Magnesium 1.5 meq/l 1.0 meq/l 1.0 meq/l Sodium 140 meq/l 140 meq/l 140 meq/l Chloride 120.5 meq/l 109.5 meq/l 108 meq/l Bicarbonate 22 meq/l 32 meq/l 32 meq/l Lactate 3 meq/l 3 meq/l 3 meq/l Dextrose 110 mg/dl 0.0 0.0 Osmolarity 296 mosm/l 287 mosm/l 286 mosm/l NORMAL BICARBONATE SOLUTIONS: HIGH BICARBONATE 4K+ SOLUTIONS: HIGH BICARBONATE 2K+ SOLUTIONS Prismasol B22GK4/0 5000 ml Prismasol BGK 4/0/1.2 5000 ml Prismasol BGK 2/0 5000 ml Potassium 4 meq/l 4 meq/l 2 meq/l Calcium 0.0 0.0 0.0 Magnesium 1.5 meq/l 1.2 meq/l 1.0 meq/l Sodium 140 meq/l 140 meq/l 140 meq/l Chloride 120.5 meq/l 110.5 meq/l 108 meq/l Bicarbonate 22 meq/l 32 meq/l 32 meq/l Lactate 3 meq/l 3 meq/l 3 meq/l Dextrose 100 mg/dl 100 mg/dl 100 mg/dl Osmolarity 296 mosm/l 295 mosm/l 291 mosm/l

TABLE OF RECOMMENDED PRESSURES FOR CRRT: ST. DOMINIC-JACKSON MEMORIAL HOSPITAL HEPARIN ANTICOAGULATION Page 5 of 5 ARTERIAL --50 mmhg -150 mmhg VENOUS +50 mmhg +150 mmhg PRE/FILTER +100 mmhg +250 mmhg BLOOD PULLED OUT OF THE VEIN POSITIVE BLOOD PUSHED BACK INTO THE VEIN POSITIVE BLOOD PUSHED THROUGH NARROW FILTER FIBERS **WILL BECOME MORE POSITIVE AS FILTER FIBERS CLOT TMP TRANSMEMBRANE PRESSURE < 0 mmhg > + 150 mmhg POSITIVE OR PLASMA WATER PUSHEDOUT OF THE WHOLE BLOOD (+VE) OR PLASMA WATER PULLED OUT OF THE WHOLE BLOOD (-VE) THROUGH THE FILTER FIBERS PORES BECOMING THE EFFLUENT **WILL BECOME MORE POSITIVE AS FILTER FIBERS PORES BLOCK EFFLUENT > + 50 mmhg - 150 mmhg POSITIVE OR THERAPY DEPENDANT *WILL BECOME MORE AS FILTER FIBERS PORES BLOCK / Date Time Physician Signature